Literature DB >> 20035054

Persistent hijacking of brain proteasomes in HIV-associated dementia.

Trung P Nguyen1, Vicki M Soukup, Benjamin B Gelman.   

Abstract

Immunoproteasome induction sustains class 1 antigen presentation and immunological vigilance against HIV-1 in the brain. Investigation of HIV-1-associated alterations in brain protein turnover by the ubiquitin-proteasome system was performed by (1) determining proteasome subunit changes associated with persistent brain inflammation due to HIV-1; (2) determining whether these changes are related to HIV-1 neurocognitive disturbances, encephalitis, and viral loads; and (3) localizing proteasome subunits in brain cells and synapses. On the basis of neurocognitive performance, virological, and immunological measurements obtained within 6 months before death, 153 autopsy cases were selected. Semiquantitative immunoblot analysis performed in the dorsolateral prefrontal cortex revealed up to threefold induction of immunoproteasome subunits LMP7 and PA28alpha in HIV-1-infected subjects and was strongly related to diagnoses of neuropsychological impairment and HIV encephalitis. Low performance on neurocognitive tests specific for dorsolateral prefrontal cortex functioning domains was selectively correlated with immunoproteasome induction. Immunohistochemistry and laser confocal microscopy were then used to localize immunoproteasome subunits to glial and neuronal elements including perikarya, dystrophic axons, and synapses. In addition, HIV loads in brain tissue, cerebrospinal fluid, and blood plasma were robustly correlated to immunoproteasome levels. This persistent "hijacking" of the proteasome by HIV-1-mediated inflammatory response and immunoproteasome induction in the brain is hypothesized to impede turnover of folded proteins in brain cells. This would disrupt neuronal and synaptic protein dynamics, contributing to HIV-1 neurocognitive disturbances.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20035054      PMCID: PMC2808094          DOI: 10.2353/ajpath.2010.090390

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  68 in total

1.  Impaired immunoproteasome assembly and immune responses in PA28-/- mice.

Authors:  T Preckel; W P Fung-Leung; Z Cai; A Vitiello; L Salter-Cid; O Winqvist; T G Wolfe; M Von Herrath; A Angulo; P Ghazal; J D Lee; A M Fourie; Y Wu; J Pang; K Ngo; P A Peterson; K Früh; Y Yang
Journal:  Science       Date:  1999-12-10       Impact factor: 47.728

2.  HIV infection and dementia.

Authors:  S Gartner
Journal:  Science       Date:  2000-01-28       Impact factor: 47.728

3.  Accumulation of beta-amyloid precursor protein in HIV encephalitis: relationship with neuropsychological abnormalities.

Authors:  B Giometto; S F An; M Groves; T Scaravilli; J F Geddes; R Miller; B Tavolato; A A Beckett; F Scaravilli
Journal:  Ann Neurol       Date:  1997-07       Impact factor: 10.422

4.  Cerebral white matter damage in HIV infection demonstrated using beta-amyloid precursor protein immunoreactivity.

Authors:  F Raja; F E Sherriff; C S Morris; L R Bridges; M M Esiri
Journal:  Acta Neuropathol       Date:  1997-02       Impact factor: 17.088

5.  Decreased levels of proteasome activity and proteasome expression in aging spinal cord.

Authors:  J N Keller; F F Huang; W R Markesbery
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

6.  Impaired proteasome function in Alzheimer's disease.

Authors:  J N Keller; K B Hanni; W R Markesbery
Journal:  J Neurochem       Date:  2000-07       Impact factor: 5.372

7.  Inhibition of the ubiquitin-proteasome system in Alzheimer's disease.

Authors:  Y A Lam; C M Pickart; A Alban; M Landon; C Jamieson; R Ramage; R J Mayer; R Layfield
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

8.  A ubiquitin-like protein which is synergistically inducible by interferon-gamma and tumor necrosis factor-alpha.

Authors:  S Raasi; G Schmidtke; R de Giuli; M Groettrup
Journal:  Eur J Immunol       Date:  1999-12       Impact factor: 5.532

9.  An essential role for type 1 interferon-gamma in terminating persistent viral infection.

Authors:  A Tishon; H Lewicki; G Rall; M Von Herrath; M B Oldstone
Journal:  Virology       Date:  1995-09-10       Impact factor: 3.616

10.  A role for the proteasome regulator PA28alpha in antigen presentation.

Authors:  M Groettrup; A Soza; M Eggers; L Kuehn; T P Dick; H Schild; H G Rammensee; U H Koszinowski; P M Kloetzel
Journal:  Nature       Date:  1996-05-09       Impact factor: 49.962

View more
  28 in total

Review 1.  Neurotoxicity of human immunodeficiency virus-1: viral proteins and axonal transport.

Authors:  Italo Mocchetti; Alessia Bachis; Valeriya Avdoshina
Journal:  Neurotox Res       Date:  2011-09-27       Impact factor: 3.911

2.  A novel role for the immunoproteasome in retinal function.

Authors:  Stacy A Hussong; Heidi Roehrich; Rebecca J Kapphahn; Marcela Maldonado; Machelle T Pardue; Deborah A Ferrington
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-09       Impact factor: 4.799

3.  Astrocyte elevated gene-1 is a novel modulator of HIV-1-associated neuroinflammation via regulation of nuclear factor-κB signaling and excitatory amino acid transporter-2 repression.

Authors:  Neha Vartak-Sharma; Benjamin B Gelman; Chaitanya Joshi; Kathleen Borgamann; Anuja Ghorpade
Journal:  J Biol Chem       Date:  2014-05-22       Impact factor: 5.157

Review 4.  A biological perspective of CSF lipids as surrogate markers for cognitive status in HIV.

Authors:  Norman J Haughey; Xiaomao Zhu; Veera Venkata Ratnam Bandaru
Journal:  J Neuroimmune Pharmacol       Date:  2013-11-08       Impact factor: 4.147

Review 5.  Mechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disorders.

Authors:  Jerel Adam Fields; Wilmar Dumaop; Leslie Crews; Anthony Adame; Brian Spencer; Jeff Metcalf; Johnny He; Edward Rockenstein; Eliezer Masliah
Journal:  Curr HIV Res       Date:  2015       Impact factor: 1.581

Review 6.  Drug induced increases in CNS dopamine alter monocyte, macrophage and T cell functions: implications for HAND.

Authors:  Peter J Gaskill; Tina M Calderon; Jacqueline S Coley; Joan W Berman
Journal:  J Neuroimmune Pharmacol       Date:  2013-03-01       Impact factor: 4.147

Review 7.  Update on HIV dementia and HIV-associated neurocognitive disorders.

Authors:  Bruce J Brew; Phillip Chan
Journal:  Curr Neurol Neurosci Rep       Date:  2014-08       Impact factor: 5.081

8.  Nuclear factor-kappa B family member RelB inhibits human immunodeficiency virus-1 Tat-induced tumor necrosis factor-alpha production.

Authors:  Michelle Kiebala; Oksana Polesskaya; Zhenqiang Yao; Seth W Perry; Sanjay B Maggirwar
Journal:  PLoS One       Date:  2010-07-29       Impact factor: 3.240

Review 9.  HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment.

Authors:  Phillip Chan; Bruce J Brew
Journal:  Curr HIV/AIDS Rep       Date:  2014-09       Impact factor: 5.071

Review 10.  Astrocyte elevated gene-1 (AEG-1) and the A(E)Ging HIV/AIDS-HAND.

Authors:  Neha Vartak-Sharma; Shruthi Nooka; Anuja Ghorpade
Journal:  Prog Neurobiol       Date:  2016-04-14       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.